ClearPoint Neuro Inc. - Common Stock (CLPT)

Frequently Asked Questions About ClearPoint Neuro Inc. - Common Stock (CLPT)

Does ClearPoint Neuro engage in partnerships or collaborations?

Yes, ClearPoint Neuro actively seeks partnerships and collaborations with various healthcare organizations, academic institutions, and other biotech companies. These partnerships are aimed at advancing research, expanding market reach, and developing new applications for their technologies.

Has ClearPoint Neuro received any FDA approvals?

Yes, ClearPoint Neuro has received FDA approvals for several of its devices and technologies. These approvals validate the safety and effectiveness of their products and are vital for their deployment in clinical settings across the United States.

How can healthcare providers learn about using ClearPoint Neuro's systems?

Healthcare providers interested in ClearPoint Neuro's systems can access training and educational resources provided by the company. These may include workshops, webinars, and product demonstrations aimed at familiarizing medical professionals with the technology and its applications.

How can investors stay informed about ClearPoint Neuro's developments?

Investors can stay informed about ClearPoint Neuro's developments by subscribing to the company's press releases, following corporate updates on financial news platforms, and reviewing filings with the Securities and Exchange Commission (SEC) that provide insights into business performance and strategic direction.

How does ClearPoint Neuro's technology improve surgical outcomes?

ClearPoint Neuro's technology improves surgical outcomes by enabling less invasive procedures, reducing recovery times and complications. The precision offered by the ClearPoint system helps ensure that the targeted therapies are delivered directly to the disease site, which can enhance treatment efficacy.

How has ClearPoint Neuro performed financially?

As a publicly traded company, ClearPoint Neuro's financial performance is reported regularly. Investors can review the company's quarterly and annual reports to gauge its revenues, expenses, and overall financial health, which are influenced by market demand for its innovative technologies.

Is ClearPoint Neuro involved in clinical trials?

Yes, ClearPoint Neuro is involved in various clinical trials aimed at evaluating the safety and efficacy of its technologies. These trials help validate the ClearPoint system's capabilities and determine its suitability for various neurological treatments.

On which stock exchange is ClearPoint Neuro Inc. listed?

ClearPoint Neuro Inc. is listed on the Nasdaq stock exchange under the ticker symbol 'CLPT.' This listing provides the company with access to public capital and enhances its visibility in the financial markets.

What are the primary target markets for ClearPoint Neuro's products?

The primary target markets for ClearPoint Neuro's products include hospitals and surgical centers that specialize in neurosurgery. The company also aims at neurosurgeons and healthcare providers who are seeking advanced solutions to improve patient outcomes and surgical precision.

What does ClearPoint Neuro Inc. do?

ClearPoint Neuro Inc. is a medical technology company that specializes in providing innovative solutions for targeting and delivering therapies to the brain. The company’s proprietary ClearPoint system utilizes advanced imaging and navigation technology to assist in minimally invasive procedures for a variety of neurological disorders.

What is ClearPoint Neuro's vision for the future?

ClearPoint Neuro envisions a future where their technologies transform the landscape of neurosurgery. The company aims to expand its product offerings, improve treatment methods, and potentially play a significant role in curing complex neurological disorders through continued innovation and research.

What is the ClearPoint system?

The ClearPoint system is a sophisticated platform that integrates imaging with surgical navigation tools. It allows neurosurgeons to visualize the brain in real time and precisely navigate to target areas for intervention, ensuring minimal disruption to surrounding healthy tissue.

What is the mission of ClearPoint Neuro?

ClearPoint Neuro's mission is to innovate and advance the field of neurosurgery by providing cutting-edge technology that enhances surgical precision and patient care. The company is dedicated to improving the lives of patients suffering from neurological disorders through its innovative solutions.

What role does imaging play in ClearPoint Neuro's offerings?

Imaging plays a crucial role in ClearPoint Neuro's offerings. The company utilizes advanced imaging technologies, such as MRI and CT scans, to accurately visualize the brain's anatomy, allowing surgeons to effectively plan and execute procedures with high precision.

What role does innovation play in ClearPoint Neuro's strategy?

Innovation is at the core of ClearPoint Neuro's strategy. The company continually invests in research and development to create new technologies and improve existing products, ensuring it remains at the forefront of the rapidly evolving field of neurosurgery.

What sets ClearPoint Neuro apart from other medical technology companies?

ClearPoint Neuro distinguishes itself from other medical technology companies through its singular focus on neurosurgical applications and its proprietary navigation technology. This specialized knowledge allows for tailored solutions that specifically address the complex needs of surgeons and patients in the neuroscience field.

What types of medical conditions does ClearPoint Neuro address?

ClearPoint Neuro's technologies are designed for treating a range of neurological conditions, including brain tumors, epilepsy, and movement disorders such as Parkinson's disease. The systems allow for precise delivery of therapies, potentially increasing the effectiveness of treatments.

When was ClearPoint Neuro founded?

ClearPoint Neuro was founded in 2004. Since its inception, the company has focused on transforming how neurosurgical procedures are performed and improving patient outcomes through the development of its advanced technologies.

Where is ClearPoint Neuro headquartered?

ClearPoint Neuro is headquartered in the United States, with its operational center located in the greater Los Angeles area, which serves as a hub for its research, development, and commercialization efforts.

What is the current price of ClearPoint Neuro Inc. - Common Stock?

The current price of ClearPoint Neuro Inc. - Common Stock is 14.70

When was ClearPoint Neuro Inc. - Common Stock last traded?

The last trade of ClearPoint Neuro Inc. - Common Stock was at 4:00 pm EDT on April 25th, 2025